TCR2 Trademark
TCR2 is a USPTO trademark filed by TCR2 THERAPEUTICS INC.. Status: Registered.
Trademark Facts
| Mark | TCR2 |
|---|---|
| Serial Number | 86660163 |
| Registration Number | 5903400 |
| Status | Registered |
| Filing Date | 2015-06-11 |
| Registration Date | 2019-11-05 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | TCR2 THERAPEUTICS INC. |
| Prosecution Events | 69 |
| Latest Event | WOAG on 2025-08-20 |
Goods & Services
Biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases | Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics